Close Menu

More articles about Clinical Proteomics

NEW YORK (GenomeWeb) — Molecular testing methods such as nucleic acid sequence-based amplification (NASBA) and qPCR, administered either in combination or separately, are superior to routinely used ELISA-based assays for diagnosing invasive aspergillosis, according to a newly published retrospect

NEW YORK (GenomeWeb News) – Shimadzu and Indigo BioSystems announced that they have formed a partnership for the development of clinical mass spectrometry workflows.

NEW YORK (GenomeWeb) – Agilent Technologies' Dako business said today that it will develop a companion diagnostic test for a cancer drug being developed by Merck.

NEW YORK (GenomeWeb) – Newomics said today that it has received from the National Institutes of Health two Small Business Innovation Research Phase I grants totaling $908,000.

NEW YORK (GenomeWeb) – Integrated Diagnostics said this week that it has obtained $47.25 million in funding, $30.25 million from the closing of its Series B round and $17 million in non-dilutive debt financing from Life Sciences Alternative Funding.

NEW YORK (GenomeWeb News) – Biodesix today said that it has closed an $8.3 million Series E round of private financing.

The story has been updated to include comments from Vermillion's conference call on Thursday.

NEW YORK (GenomeWeb News) – The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and MRM Proteomics said today that they are collaborating with the Jain Foundation on research into biomarkers for muscular dystrophy.

NEW YORK (GenomeWeb News) – Applied Proteomics today said that it will collaborate with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) on the discovery and development of molecular diagnostic tests for colon and pancreatic cancer.

NEW YORK (GenomeWeb News) – Researchers at Washington University School of Medicine have received a nearly $2 million grant from the Bill and Melinda Gates Foundation to identify biomarkers and develop a molecular diagnostic test for onchocerciasis, commonly called river blindness.

NEW YORK (GenomeWeb News) – BG Medicine said after the close of the market Friday that it has been notified by Nasdaq for the third time in less than a year that it does not fulfill a requirement for continued listing on the exchange.

A joint effort by The Scripps Research Institute and the Salk Institute for Biological Studies has provided the broadest look yet in vivo of a class of proteins that linger in the body for months or even years, rather then being replaced or refreshed after days or hours

NEW YORK (GenomeWeb News) – The US Food and Drug Administration said yesterday that it has granted BioMérieux's Vitek MS clinical microbiology mass spectrometry system 510(k) de novo clearance.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it will collaborate with the Newman-Lakka Institute for Personalized Cancer Care at Floating Hospital for Children at Tufts Medical Center on methods for detecting and tracking blood-based protein biomarkers for various cancers.

NEW YORK (GenomeWeb News) – Biodesix has secured Medicare coverage for its VeriStrat lung cancer test, the company announced today.

NEW YORK (GenomeWeb News) – Myriad Genetics today said that its Myriad RBM subsidiary has formed a research collaboration with DaVita Labs to discover protein-based biomarkers that could be used to benefit dialysis patients.

NEW YORK (GenomeWeb News) – Bruker said today it has signed an exclusive patent license agreement with 3M Company that allows it to include in its products patented 3M technology related to MALDI mass spec imaging.

In attempting to diagnose a set of congenital disorders of glycosylation, a team from Sanford Burnham Medical Research Institute has highlighted some important pitfalls of using sequencing results to inform clinical diagnosis, specifically, the potential of somatic mosaicism to c

NEW YORK (GenomeWeb News) – Vermillion reported after the close of market Wednesday that its first-quarter revenues rose 5 percent to $328,000 from $312,000 in Q1 2012, beating the consensus Wall Street estimate of $300,000.

NEW YORK (GenomeWeb News) – Biomarker-based diagnostics company Nuclea Biotechnologies today announced a partnership with Wilex aimed at better managing the treatment of metastatic breast cancer.

Pages

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.